000285368 001__ 285368
000285368 005__ 20260302145752.0
000285368 0247_ $$2doi$$a10.1016/j.tjpad.2026.100516
000285368 0247_ $$2pmid$$apmid:41722234
000285368 0247_ $$2pmc$$apmc:PMC12934325
000285368 0247_ $$2ISSN$$a2274-5807
000285368 0247_ $$2ISSN$$a2426-0266
000285368 037__ $$aDZNE-2026-00232
000285368 041__ $$aEnglish
000285368 082__ $$a610
000285368 1001_ $$0P:(DE-2719)2000032$$aJessen, Frank$$b0$$eFirst author$$udzne
000285368 245__ $$aLow number of patients qualifying for amyloid targeting immunotherapy.
000285368 260__ $$a[Paris]$$bElsevier Masson SAS$$c2026
000285368 3367_ $$2DRIVER$$aarticle
000285368 3367_ $$2DataCite$$aOutput Types/Journal article
000285368 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1772459787_18953$$xEditorial
000285368 3367_ $$2BibTeX$$aARTICLE
000285368 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000285368 3367_ $$00$$2EndNote$$aJournal Article
000285368 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000285368 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000285368 773__ $$0PERI:(DE-600)2782183-3$$a10.1016/j.tjpad.2026.100516$$gVol. 13, no. 3, p. 100516 -$$n3$$p100516$$tThe journal of prevention of Alzheimer's disease$$v13$$x2274-5807$$y2026
000285368 8564_ $$uhttps://pub.dzne.de/record/285368/files/DZNE-2026-00232.pdf$$yRestricted
000285368 8564_ $$uhttps://pub.dzne.de/record/285368/files/DZNE-2026-00232.pdf?subformat=pdfa$$xpdfa$$yRestricted
000285368 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2000032$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000285368 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000285368 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2025-11-11$$wger
000285368 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2025-11-11$$wger
000285368 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJPAD-J PREV ALZHEIM : 2022$$d2025-11-11
000285368 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-11-11
000285368 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-11-11
000285368 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2025-11-11
000285368 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-11-11
000285368 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2025-11-11
000285368 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-11-11
000285368 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-11-11
000285368 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-11-11
000285368 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2025-05-28T09:11:42Z
000285368 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2025-05-28T09:11:42Z
000285368 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2025-05-28T09:11:42Z
000285368 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bJPAD-J PREV ALZHEIM : 2022$$d2025-11-11
000285368 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2025-11-11
000285368 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2025-11-11
000285368 9201_ $$0I:(DE-2719)1011102$$kAG Jessen$$lClinical Alzheimer’s Disease Research$$x0
000285368 980__ $$ajournal
000285368 980__ $$aEDITORS
000285368 980__ $$aVDBINPRINT
000285368 980__ $$aI:(DE-2719)1011102
000285368 980__ $$aUNRESTRICTED